Troy E. Messick,Garry R. Smith,Allen B. Reitz,Paul M. Lieberman,Mark E. McDonnell,Yan Zhang,Venkata Velvadapu
申请号：
US16519590
公开号：
US20200181078A1
申请日:
2019.07.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Pharmaceutical compositions of the invention comprise EBNA1 inhibitors useful for the treatment of diseases caused by EBNA1 activity such as cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis. Pharmaceutical compositions of the invention also comprise EBNA1 inhibitors useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. Pharmaceutical compositions of the invention also comprise EBNA1 inhibitors useful for the treatment of diseases caused by lytic Epstein-Barr Virus (EBV) infection.
